Follow-up study of subjects who participated in the IUGR-1, IUGR-2 and PROGRAM/PREMS study during childhood and early adulthood - Long term effects of growth hormone many years after discontinuation

Follow-up study of subjects who participated in the IUGR-1, IUGR-2 and PROGRAM/PREMS study during childhood and early adulthood - Long term effects of growth hormone many years after discontinuation - Follow-up study of ex-participants of the IUGR-1, 2 and PROGRAM/PREMS study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON47841

Enrollment

400

Registered

2015-02-18

Start date

2015-05-18

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiovasculaire ziektes Short children born small for gestational age

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Former participant of the IUGR-1, IUGR-2 or PROGRAM/PREMS study

Exclusion criteria

Exclusion criteria: Duration of growth hormone treatment less than 4 years

Design outcomes

Primary

Measure	Time frame
Insulin resistance	—

Secondary

Measure	Time frame
Blood pressure, body composition, lipid profile, endothelial function and gonadal function.	—

Countries

Netherlands

Outcome results